MedPath

Feasibility Study of an Automated Point-of-Care Urine Diagnostic Device for Pregnancy

Conditions
Pregnancy Related
Interventions
Diagnostic Test: Pregnancy test
Registration Number
NCT03575286
Lead Sponsor
Voyant Diagnostics, Inc.
Brief Summary

The primary purpose of this observational study is to demonstrate the feasibility of an automated point-of-care urine diagnostic device in determining the pregnancy status of patients through urine samples collected from patients at Northwestern University. Our hypothesis is that this automated point-of-care urine diagnostic device will be able to accurately determine a patient's pregnancy status at least 95% of the time.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
123
Inclusion Criteria
  • Patient age 18 years and older, upper age limit of 45 years
  • Female patient
  • Patients undergoing any procedures for pregnancy diagnosis and confirmation
  • English speaking

The following special population will be included:

  • Pregnant women
Exclusion Criteria
  • Adults unable to consent
  • Individuals who are not yet adults (infants, children, and teenagers)
  • Prisoners

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Non-pregnant femalePregnancy testPatient has been determined not pregnant with a urine pregnancy test and, if applicable, a serum pregnancy test performed at Northwestern University.
Pregnant femalePregnancy testPatient has been determined pregnant with a urine pregnancy test and, if applicable, a serum pregnancy test performed at Northwestern University.
Primary Outcome Measures
NameTimeMethod
Accuracy in determining pregnancy statusTime of collection - 1 month post collection

Compare qualitative pregnancy test results generated by Voyant's device with urine pregnancy test result(s) and, if applicable, serum pregnancy test results performed at Northwestern University. From this comparison, we will determine the accuracy of Voyant's device. We will be using the same urine sample used at Northwestern.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Northwestern University

🇺🇸

Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath